Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial

نویسندگان

  • Andre Gustavo Daher Vianna
  • Claudio Silva de Lacerda
  • Luciana Muniz Pechmann
  • Michelle Garcia Polesel
  • Emerson Cestari Marino
  • Victoria Zeghbi Cochenski Borba
  • Fellype de Carvalho Barreto
چکیده

BACKGROUND Several antidiabetic therapies affect bone metabolism. Sulfonylureas have the lowest impact on bone among oral antidiabetics. The objective of this study is to compare the effects of vildagliptin and gliclazide modified release (MR) on bone turnover markers (BTMs) and bone mineral density (BMD) in postmenopausal women with uncontrolled type 2 diabetes (T2D). METHODS Forty-two postmenopausal women with uncontrolled T2D were randomly allocated into vildagliptin or gliclazide MR (control) groups. The primary endpoint was the change in the BTMs in months 6 and 12 compared with the baseline. The secondary endpoint was the variation in the BMD, which was assessed via dual-energy X-ray absorptiometry at the lumbar spine, femoral neck and total hip at baseline and month 12. RESULTS After a 12-month treatment, the BTM serum carboxy-terminal telopeptide of type 1 collagen increased 0.001 ± 0.153 ng/mL in the vildagliptin group versus 0.008 ± 0.060 ng/mL in the gliclazide MR group (p = 0.858). The serum osteocalcin, serum amino-terminal propeptide of procollagen type I and urinary amino-terminal telopeptide of type 1 collagen remained stable in both groups, and there was no statistically significant difference between the effect of vildagliptin and gliclazide MR on these variables. The lumbar spine BMD did not change in the vildagliptin or gliclazide MR groups after a 12-month treatment (0.000 ± 0.025 g/cm2 versus -0.008 ± 0.036, respectively, p = 0.434). Furthermore, there was a similar lack of change in the femoral neck and total hip BMD values in both treatments. CONCLUSIONS Bone turnover markers and BMD remained unchanged after a 12-month treatment in both groups, which suggests that vildagliptin has the same safety profile as gliclazide MR on bone metabolism. Trial Registration ClinicalTrials.gov number NCT01679899.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Effects of multiparity and duration of breast-feeding on maternal bone mineral density in post-menopausal Kurdish women: A retrospective study

Introduction:There is considerable amount of controversy about the long term effects of multiparity and duration of breast-feeding on maternal bone mineral density after menopause. This study was conducted to determine whether multiple pregnancy and prolonged duration of breast-feeding are independent predictors of low bone mass in post-menopausal Kurdish women. M...

متن کامل

رابطه‌ی بین میزان فعالیت بدنی و میزان کلسیم مصرفی روزانه با شاخص‌های منتخب تن سنجی و میزان تراکم استخوان در زنان یائسه مراجعه کننده به مرکز تراکم استخوان شهر رشت

Background and Objective: This study was carried out to investigate the relationship between the amount of physical activity and daily calcium intake with body mass index and the amount of bone density in post-menopausal female patients. Materials and Methods: This descriptive-cross sectional study was performed on 80 post-menopausal women with mean age of 58.13±7.59 years and BMI mean of 26.69...

متن کامل

Assessment of bone mineral density with dual energy X-ray absorptiometry in pre- and post-menopausal women

Background: Osteoporosis is a chronic disease that contributes substantially to decrease physical activity and decline in the quality of life. Osteoporosis can be diagnosed easily with the use of dual-energy X-ray absorptiometry (DXA) equipment. The aim of this study was to investigate the magnitude of bone loss on proximal femur and lumbar spine LS in pre- and post-menopausal women f...

متن کامل

Effects of specific post-menopausal hormone therapies on bone mineral density in post-menopausal women: a meta-analysis.

BACKGROUND Long-term post-menopausal hormone therapy (pHT) was often regarded as first-line therapy to prevent fractures in post-menopausal women, a recommendation under scrutiny given the benefit-risk profile of the Women's Health Initiative results of the estrogen-progestin combination. Apart from controlled clinical studies providing data with fractures as an end point, measures of lumbar an...

متن کامل

Bone mineral density evaluation of post menopausal women who referred to Shahid Mohammadi hospital BMD center

Introduction: Osteoporosis is an important public health problem. Osteoporosis characterized by low bone mass with micro architectural disruption and skeletal fragility resulting increased risk of fracture .The aim of this study was to evaluate the Bone mineral density in post menopausal women who referred to Shahid Mohamadi hospital BMD center. Methods: In this cross sectional study 404 postme...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 9  شماره 

صفحات  -

تاریخ انتشار 2017